| 000 | 01200 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518031834.0 | ||
| 264 | 0 | _c20220406 | |
| 008 | 202204s 0 0 eng d | ||
| 022 | _a1747-6356 | ||
| 024 | 7 |
_a10.1080/17476348.2019.1600824 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRocco, Danilo | |
| 245 | 0 | 0 |
_aFirst-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development. _h[electronic resource] |
| 260 |
_bExpert review of respiratory medicine _c03 2022 |
||
| 300 |
_a315-321 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xgenetics |
| 700 | 1 | _aDella Gravara, Luigi | |
| 700 | 1 | _aBattiloro, Ciro | |
| 700 | 1 | _aGridelli, Cesare | |
| 773 | 0 |
_tExpert review of respiratory medicine _gvol. 16 _gno. 3 _gp. 315-321 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17476348.2019.1600824 _zAvailable from publisher's website |
| 999 |
_c29525844 _d29525844 |
||